89Bio, Inc.(ETNB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ETNB 89Bio, Inc.

Pre-Market Trading 12-19 04:07:30 EST

7.61

-0.37

-4.64%

High8.05	Low7.40	Vol1.54M
Open8.00	D1 Closing7.98	Amplitude8.15%
Mkt Cap894.80M	Tradable Cap605.97M	Total Shares117.58M
T/O11.99M	T/O Rate1.93%	Tradable Shares79.63M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"ETNB","market":"US","secType":"STK","nameCN":"89Bio, Inc.","latestPrice":7.61,"timestamp":1734555600000,"preClose":7.98,"halted":0,"volume":1540718,"delay":0,"floatShares":79628700,"shares":117582220,"eps":-3.012954,"marketStatus":"Pre-Market Trading","change":-0.37,"latestTime":"12-19 04:07:30 EST","open":8,"high":8.05,"low":7.4,"amount":11987086.0976,"amplitude":0.081454,"askPrice":7.97,"askSize":12,"bidPrice":3.13,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.012954,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1734618600000},"marketStatusCode":1,"adr":0,"listingDate":1573448400000,"exchange":"NASDAQ","adjPreClose":7.61,"postHourTrading":{"tag":"盘后","latestPrice":7.61,"preClose":7.61,"latestTime":"18:08 EST","volume":18677,"amount":142132.35,"timestamp":1734563326041},"volumeRatio":1.8718750324239852,"impliedVol":0.7688,"impliedVolPercentile":0.4303},"requestUrl":"/m/hq/s/ETNB/wiki","defaultTab":"wiki","newsList":[{"id":"2491691557","title":"New Strong Sell Stocks for November 16th","url":"https://stock-news.laohu8.com/highlight/detail?id=2491691557","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491691557?lang=en_us&edition=fundamental","pubTime":"2024-12-16 18:59","pubTimestamp":1734346740,"startTime":"0","endTime":"0","summary":"Here are three stocks added to the Zacks Rank #5  List today:. ClevelandCliffs CLF is the largest producer of iron ore pellets in North America. The Zacks Consensus Estimate for its current year earnings has been revised almost 84.6% downward over the last 60 days.89BIO ETNB is clinical-stage biopharmaceutical company which is focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. The Zacks Consensus Estimate for its current year earnings has been revised 36.2% downward over the last 60 days.MarineMax HZO is the nation's largest recreational boat and yacht retailer. The Zacks Consensus Estimate for its current year earnings has been revised 24.6% downward over the last 60 days.Want the latest recommendations from Zacks Investment Research?Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report. To read this article on Zacks.com click here.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/0LyNBdidj_xj8ehhpBX8YA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4d335bd14592d76b641324eb63233abe","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/0LyNBdidj_xj8ehhpBX8YA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4d335bd14592d76b641324eb63233abe"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/strong-sell-stocks-november-16th-105900112.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ETNB","BK4588","BK4139","BK4585","BK4006","BK4200","HZO","CLF"],"gpt_icon":0},{"id":"2489104301","title":"Why Is 89bio, Inc. (ETNB) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds?","url":"https://stock-news.laohu8.com/highlight/detail?id=2489104301","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489104301?lang=en_us&edition=fundamental","pubTime":"2024-12-05 02:02","pubTimestamp":1733335328,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 10 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds.In this article, we are going to take a look at where 89bio, Inc.  stands against the other small-cap biotech stocks.Revolutionizing Healthcare and Economy: The Rapid Growth of Biotechnology. The biotechnology sector is expanding quickly due to rising demand for novel therapies, technological advances, and government assistance. Advances in fields like gene editing, sequencing, personalized medicine, and artificial intelligence are making new techniques possible, while the aging population and growing healthcare demands are driving a robust market for new treatments. According to a report by McKinsey & Company, venture capital firms made approximately $52 billion in global investments in therapeutic-focused biotech companies between 2019 and 2021. Two-thirds of this sum was given to platform-tech start-up companies.This year  started strongly for the biotechnology sector ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/vltckEnnUuES2V6oh1IJuw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/272578386575f8f9a3f5a3b25844931b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/vltckEnnUuES2V6oh1IJuw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/272578386575f8f9a3f5a3b25844931b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-89bio-inc-etnb-among-180208816.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":[".IXIC","BK4585","CAGR","BK4159","PSQ","SQQQ","TQQQ","QLD","BK4139","MNQmain","QID","NQmain","ETNB"],"gpt_icon":1},{"id":"2487593499","title":"89Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2487593499","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487593499?lang=en_us&edition=fundamental","pubTime":"2024-11-30 02:30","pubTimestamp":1732905000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241129:nTUA9FZWZW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BGHQF748.EUR","NDAQ","LU2095319765.USD","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4112","BK4139","IE00BKPKM429.USD","BK4588","LU2210149790.SGD","IE00B64PRP62.GBP","BK4585","ETNB"],"gpt_icon":0},{"id":"2486205834","title":"89bio to Participate in the 7th Annual Evercore HealthCONx Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2486205834","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486205834?lang=en_us&edition=fundamental","pubTime":"2024-11-27 05:05","pubTimestamp":1732655100,"startTime":"0","endTime":"0","summary":"SAN FRANCISCO, Calif., Nov. 26, 2024  -- 89bio, Inc.  , a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Company’s Management will participate in a fireside chat at the 7th Annual Evercore HealthCONx Conference on Tuesday, December 3, 2024 at 8:20 AM ET and participate in one-on-one investor meetings.The webcast of the fireside chat will be accessible in the investor section of89bio’s website. A replay of the webcast will be available for approximately 30 days following the conference.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/OBcqXzIqiNQZbGfiTeetOA--~B/aD02ODt3PTE4MTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/b32d53353b31091b62fe237e474ab39c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/OBcqXzIqiNQZbGfiTeetOA--~B/aD02ODt3PTE4MTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/b32d53353b31091b62fe237e474ab39c"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/89bio-participate-7th-annual-evercore-210500008.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4139","ETNB"],"gpt_icon":0},{"id":"2483753653","title":"89bio announces new analyses of data from Phase 2b ENLIVEN trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2483753653","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483753653?lang=en_us&edition=fundamental","pubTime":"2024-11-15 21:15","pubTimestamp":1731676536,"startTime":"0","endTime":"0","summary":"89bio (ETNB) announced new analyses of data from the Phase 2b ENLIVEN trial evaluating pegozafermin in metabolic dysfunction-associated steatohepat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/89bio-announces-new-analyses-of-data-from-phase-2b-enliven-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/89bio-announces-new-analyses-of-data-from-phase-2b-enliven-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ETNB","BK4585","BK4139"],"gpt_icon":0},{"id":"2483373818","title":"89Bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests From the Enliven Phase 2B Trial in Mash Patients at Aasld the Liver Meeting® 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2483373818","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483373818?lang=en_us&edition=fundamental","pubTime":"2024-11-15 21:05","pubTimestamp":1731675900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nTUA1CQFYD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4585","ETNB"],"gpt_icon":0},{"id":"2483358338","title":"BUZZ-U.S. STOCKS ON THE MOVE-BankUnited, Natera, Adaptimmune","url":"https://stock-news.laohu8.com/highlight/detail?id=2483358338","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483358338?lang=en_us&edition=fundamental","pubTime":"2024-11-14 00:01","pubTimestamp":1731513678,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-BankUnited, Natera, AdaptimmuneEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: ht","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nL4N3MK1NK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SWKS","ALUR","CAT","AMPS","ADAP","BKU","GDYN","VVX","MVST","LU1914381329.SGD","KLAC","HTLD","PAY","AMGN","KNX","SAIA","CAVA","LU2756315318.SGD","LU0683600562.USD","SYRS","SSYS","BK4211","PET","MARA","LU2098885051.SGD","NTRA","CTRA","CART","SAVE","PLTR","DAVE","SG9999015986.USD","BRTX","ODFL","POAI","ETNB","SPOT","TSLA","BW","COTY","HON","GCTK","GEV","BARC.UK","MPWR","ALB","LU0964806797.USD","RIVN","LXEO"],"gpt_icon":1},{"id":"2483075004","title":"BUZZ-89bio slips after $125 mln stock deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2483075004","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483075004?lang=en_us&edition=fundamental","pubTime":"2024-11-13 20:56","pubTimestamp":1731502616,"startTime":"0","endTime":"0","summary":"**  Shares of 89Bio ETNB.O down 3.9% at $8.70 premarket after overnight follow-on priced. **  Liver disease specialist late Tues sold ~14.7 mln shares, including 3.25 mln pre-funded warrants, at $8.50 for $125 mln gross proceeds. ** Offering size boosted from $100 mln, priced at 6.1% discount to last sale. ** Co to use net proceeds to fund development of lead candidate, pegozafermin, to treat metabolic dysfunction-associated steatohepatitis , fatty liver disease formerly known as NASH. ** Goldman Sachs, Leerink and Evercore jt bookrunners for offering. ** Co has ~106.13 mln shares outstanding for $960 mln market value. **  Through Tues, stock off 19% YTD and well below one-year high of $16.63 hit in early Mar. ** Co slated to present Phase IIb trial data for pegozafermin at the 75th annual \"Liver Meeting\" healthcare conf held in San Diego from Nov 15-19","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nL6N3MK0IN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4516","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU2237443895.HKD","LU2237443382.USD","BK4533","IE00BFXG1179.USD","BK4127","EVR","IE0034235188.USD","IE0002270589.USD","BK4504","LU1668664300.SGD","BK4588","BK4550","BK4585","LU2237443465.HKD","LU2237443978.SGD","LU2237443622.USD","BK4552","IE0004091025.USD","ETNB","LU0106831901.USD","IE0004086264.USD","IE00B19Z3581.USD","BK4139","LU1791807156.HKD","LU2237438978.USD","LU2237443549.SGD"],"gpt_icon":0},{"id":"2483852071","title":"89bio Prices $125 Million Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2483852071","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483852071?lang=en_us&edition=fundamental","pubTime":"2024-11-13 18:13","pubTimestamp":1731492825,"startTime":"0","endTime":"0","summary":"89bio (ETNB) said late Tuesday it priced its public offering of 11.5 million shares at $8.50 per share, and pre-funded warrants to purchase up to about 3.3 million shares at $8.499 per warrant for gro","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4139","ETNB"],"gpt_icon":0},{"id":"2483902577","title":"89bio drops 2%, prices $125M stock offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2483902577","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483902577?lang=en_us&edition=fundamental","pubTime":"2024-11-13 14:28","pubTimestamp":1731479331,"startTime":"0","endTime":"0","summary":"Clinical-stage biopharmaceutical company 89bio (NASDAQ:ETNB) priced its previously announced upsized underwritten public offering of 11.46M shares at a price per share of $8.50 and pre-funded warrants to purchase up to 3.25M shares at a public offering price of $8.499.  Underwriters have","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4283481-89bio-drops-2-prices-125m-stock-offering","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_trending_news","symbols":["QID","NQmain",".IXIC","ETNB","BK4585","TQQQ","MNQmain","PSQ","QLD","BK4139","SQQQ"],"gpt_icon":0},{"id":"2483204335","title":"BRIEF-89Bio, Inc. Announces Upsized Pricing Of $125.0 Million Public Offering Of Common Stock And Pre-Funded Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2483204335","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483204335?lang=en_us&edition=fundamental","pubTime":"2024-11-13 12:59","pubTimestamp":1731473963,"startTime":"0","endTime":"0","summary":"BRIEF-89Bio, Inc. Announces Upsized Pricing Of $125.0 Million Public Offering Of Common Stock And Pre-Funded WarrantsNov 13 (Reuters) - 89Bio Inc ETNB.O:89BIO, INC. ANNOUNCES UPSIZED PRICING OF $125.0","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nTUA6SGGTR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4585","ETNB"],"gpt_icon":0},{"id":"2483487970","title":"89Bio, Inc. Announces Upsized Pricing of $125.0 Million Public Offering of Common Stock and Pre-Funded Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2483487970","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483487970?lang=en_us&edition=fundamental","pubTime":"2024-11-13 12:58","pubTimestamp":1731473881,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nTUA6SGGTR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4139","ETNB"],"gpt_icon":0},{"id":"2483048718","title":"89Bio Inc - Prices Upsized Public Offering of 11.46 Mln Shares at $8.50 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2483048718","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483048718?lang=en_us&edition=fundamental","pubTime":"2024-11-13 12:58","pubTimestamp":1731473881,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nTUA6SGGTR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4139","ETNB"],"gpt_icon":0},{"id":"2483057928","title":"89bio announces $100M common stock offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2483057928","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483057928?lang=en_us&edition=fundamental","pubTime":"2024-11-13 05:06","pubTimestamp":1731445603,"startTime":"0","endTime":"0","summary":"89bio (ETNB) announced that it has commenced an underwritten public offering of $100M of shares of its common stock or, in lieu of common stock to ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/89bio-announces-100m-common-stock-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/89bio-announces-100m-common-stock-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4585","ETNB"],"gpt_icon":0},{"id":"2483054430","title":"89Bio Inc - Commences $100 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2483054430","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483054430?lang=en_us&edition=fundamental","pubTime":"2024-11-13 05:01","pubTimestamp":1731445291,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nTUA4BM99F:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ETNB","BK4585","BK4139"],"gpt_icon":0},{"id":"2483054116","title":"89Bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2483054116","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483054116?lang=en_us&edition=fundamental","pubTime":"2024-11-13 05:01","pubTimestamp":1731445291,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nTUA4BM99F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4139","ETNB"],"gpt_icon":0},{"id":"2483577160","title":"89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2483577160","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483577160?lang=en_us&edition=fundamental","pubTime":"2024-11-13 05:01","pubTimestamp":1731445260,"startTime":"0","endTime":"0","summary":"SAN FRANCISCO, Nov. 12, 2024  -- 89bio, Inc.  , a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that it has commenced an underwritten public offering of $100 million of shares of its common stock or, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase shares of its common stock. In addition, 89bio is expected to grant the underwriters of the offering an option for a period of 30 days to purchase up to an additional $15 million of shares of its common stock at the public offering price, less the underwriting discounts and commissions. The proposed public offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering. All of the securities to be sold in the offering are being offered by 89b","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/OBcqXzIqiNQZbGfiTeetOA--~B/aD02ODt3PTE4MTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/b32d53353b31091b62fe237e474ab39c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/OBcqXzIqiNQZbGfiTeetOA--~B/aD02ODt3PTE4MTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/b32d53353b31091b62fe237e474ab39c"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/89bio-inc-announces-proposed-underwritten-210100794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4139","ETNB"],"gpt_icon":0},{"id":"2482478945","title":"Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (JANX), 89bio (ETNB) and Ardent Health Partners, Inc. (ARDT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2482478945","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482478945?lang=en_us&edition=fundamental","pubTime":"2024-11-11 21:10","pubTimestamp":1731330617,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Janux Therapeutics Inc (JANX – Research Report), 89b...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-janux-therapeutics-inc-janx-89bio-etnb-and-ardent-health-partners-inc-ardt?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-janux-therapeutics-inc-janx-89bio-etnb-and-ardent-health-partners-inc-ardt?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JANX","ARDT","HCSG","BK4539","BK4137","BK4139","ETNB","BK4585","BK4185"],"gpt_icon":0},{"id":"2482878307","title":"89bio Price Target Maintained With a $29.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2482878307","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482878307?lang=en_us&edition=fundamental","pubTime":"2024-11-11 20:36","pubTimestamp":1731328560,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ETNB/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 11, 2024 07:36 ET (12:36 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ETNB"],"gpt_icon":0},{"id":"1172011989","title":"Stock Track | 89Bio Soars Despite Mixed Q3 Results as Investors Focus on Future Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=1172011989","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172011989?lang=en_us&edition=fundamental","pubTime":"2024-11-09 05:04","pubTimestamp":1731099863,"startTime":"0","endTime":"0","summary":"Shares of 89Bio, Inc.  surged 5.32% on Thursday, November 8th, despite the biopharmaceutical company reporting mixed results for the third quarter of 2024. The stock's rally came as investors appeared to look past the company's larger-than-expected loss and focused on potential positive signs for the future.According to the earnings report, 89Bio posted an adjusted loss of $1.39 per share for the quarter ended September 30, wider than analysts' consensus estimate of a loss of $0.64 per share. Ho","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Stock Track | 89Bio Soars Despite Mixed Q3 Results as Investors Focus on Future Potential","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ETNB"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.89bio.com","stockEarnings":[{"period":"1week","weight":-0.0535},{"period":"1month","weight":-0.0458},{"period":"3month","weight":-0.082},{"period":"6month","weight":-0.1068},{"period":"1year","weight":-0.2986},{"period":"ytd","weight":-0.3187}],"compareEarnings":[{"period":"1week","weight":-0.0349},{"period":"1month","weight":-0.0032},{"period":"3month","weight":0.0268},{"period":"6month","weight":0.0767},{"period":"1year","weight":0.2347},{"period":"ytd","weight":0.2335}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis; and for the treatment of severe hypertriglyceridemia. 89bio, Inc. was incorporated in 2018 and is headquartered in San Francisco, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.179236},{"month":2,"riseRate":0.8,"avgChangeRate":0.131113},{"month":3,"riseRate":0.4,"avgChangeRate":-0.076134},{"month":4,"riseRate":0.4,"avgChangeRate":-0.12055},{"month":5,"riseRate":0.6,"avgChangeRate":0.054165},{"month":6,"riseRate":0.6,"avgChangeRate":-0.022743},{"month":7,"riseRate":0.6,"avgChangeRate":0.088741},{"month":8,"riseRate":1,"avgChangeRate":0.16496},{"month":9,"riseRate":0.4,"avgChangeRate":-0.059438},{"month":10,"riseRate":0.4,"avgChangeRate":-0.003798},{"month":11,"riseRate":0.6,"avgChangeRate":-0.000698},{"month":12,"riseRate":0.333333,"avgChangeRate":0.093242}],"exchange":"NASDAQ","name":"89Bio, Inc.","nameEN":"89Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"89Bio, Inc.(ETNB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest 89Bio, Inc.(ETNB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"89Bio, Inc.,ETNB,89Bio, Inc.股票,89Bio, Inc.股票老虎,89Bio, Inc.股票老虎国际,89Bio, Inc.行情,89Bio, Inc.股票行情,89Bio, Inc.股价,89Bio, Inc.股市,89Bio, Inc.股票价格,89Bio, Inc.股票交易,89Bio, Inc.股票购买,89Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"89Bio, Inc.(ETNB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest 89Bio, Inc.(ETNB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction